As of March 2024, Wegovy is approved to assist decrease the potential risk of heart attack, stroke, and cardiovascular Loss of life in people with heart disease and possibly overweight or being overweight.four.two Posology and means of administration Simulect should be prescribed only by physicians who are experienced in the usage of immunosuppress